We are a biotechnology company focused on applying stem cell technology in the field of regenerative medicine to bring effective, patient-specific therapies to the bedside
Research with embryonic stem cells is quickly moving from the lab to the clinic, and the promise of these "master cells" is fast becoming a reality. Stay informed and engage in an active dialogue about the latest developments in regenerative medicine that could revolutionize medicine and patient care.
Contribute.
An investment in the regenerative medicine sector can help hasten the day that treatments using pluripotent stem cells enter the clinic. Treatments and cures using these "master" cells have the potential to change the field of medicine, with long-term revenue potential in the hundreds of billions of dollars.
Invest.
The day is drawing nearer when a host of debilitating diseases and conditions can be not only treated but actually cured via therapies using embryonic stem cells. Stay abreast of the latest developments and meet others interested in this promising field.
Discuss.Stem Cells
02/11/2010
CLONING AND STEM CELLS, Volume 11, Number 2
11/01/2009
Stem Cells
06/11/2009
Stem Cells
01/02/2009
Blood: doi:10.1182/blood
05/15/2008
Washington Post - Page A1
08/30/2010
Boston Business Journal
08/26/2010
Worcester Telegram-Gazette
08/25/2010
ABC News online
08/25/2010
Reuters
08/25/2010
BioWorld
08/25/2010